Profile: Nanomi B.V. specializes in the development of precisely defined functional emulsions and micro & nanospheres. We offer technology for the fabrication of monodisperse microspheres for parental, sustained released and drug delivery applications. Our proprietary microsieve™ emulsification process enables the processing of a large variety of polymer/active combinations into microspheres, with unsurpassed predictability in size and performance. Our activity portfolio includes microsphere fabrication with PLGA, PLLA, PLGA-PEG, PLGA-PCL, PMMA & PEG-PBT, and the encapsulation of antibodies, progesterone, doxycycline, cyclosporine A & model compounds such as lysozyme, BSA & vitamin B12. Our flexible & customizable process makes new products & therapies possible, and transforms difficult to process formulations into novel drug delivery vehicles. The microsieve™ emulsification process can be conveniently scaled to any size by increasing the number of pores on our membranes. We provide expertise in the production of tailor-made, monodisperse & high-value emulsions and micro & nanospheres, for utilization in other applications such as diagnostics, molecular imaging, research & analysis. We can encapsulate gases, nanoparticles, colloids and other molecules that are relevant in the life sciences. We have developed various droplet and particle-based systems such as lipid microspheres, fluorescent polyethylene & polystyrene monospheres, ultrasound contrast agents, colored magnetic microspheres & biodegradable microspheres with encapsulated drugs.